Find your next paid study

Pulmonary Hypertension Association, Inc.NCT04071327

~$10 – $1,050

Actual pay is set by the research site.

Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT)

The Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT) study is a randomized trial to determine and assess the efficacy of integrated trea…

NocturiaInsomnia

Atlanta VA Medical CenterNCT06110091

Actual pay is set by the research site.

Phase 1

Phase I/II Trial of Gabapentin Plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation

This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergo…

Head and Neck CancerLocally Advanced Head and Neck Carcinoma

Natalie LockneyNCT05156060

~$150 – $4,500

Actual pay is set by the research site.

Effectiveness and Implementation of a Brief Motivational Intervention to Increase Physical Activity for World Trade Center Health Program Cancer Survivors

The goal of this study is to test a brief motivational intervention to increase physical activity in a group of cancer survivors who are participants in the Wo…

Cancer

Stony Brook UniversityNCT07215091

Actual pay is set by the research site.

Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device

The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to ass…

Blood Pressure

The University of Texas Health Science Center, HoustonNCT06719518

Actual pay is set by the research site.

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subj…

Vascular DiseaseDissectionDissection Aortic Aneurysm+5 more

W.L.Gore & AssociatesNCT06658730

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Randomized, Double-Blind, Phase 1/2a Study to Evaluate the Safety, Tolerability, PK and PD of DB-2304 for Injection in Healthy Adult Participants and Participants With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus

A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

DualityBio Inc.NCT06625671

~$500 – $10,500

Actual pay is set by the research site.

Healthy AgingHealth Knowledge, Attitudes, PracticeSocial Responsibility+2 more

African Americans (AA) Communities Speak: Partnering With AA in the North and South to Train Palliative Care Clinicians to Address Interpersonal and Systemic Racism and Provide Culturally Aligned Care.

African Americans are less likely to receive quality end-of-life (EoL) care. Addressing disparities in EoL care will need efforts to support a better understan…

University of Alabama at BirminghamNCT05908487

Actual pay is set by the research site.

Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

Estrogen-dominant gender-affirming hormone therapy (GAHT) is standard of care for transgender women and gender-diverse individuals and typically consists of es…

Muscle Mass and Strength

Massachusetts General HospitalNCT07400419

Actual pay is set by the research site.

Phase 2

Phase II Clinical Trial Combining the Hedgehog Inhibitor Vismodegib With the PD-L1 Inhibitor Atezolizumab in Patients With Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

This trial will treat patients with platinum resistant ovarian, fallopian tube or primary peritoneal cancer as defined by a progression free interval within si…

Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaPARP Inhibitor+1 more

Ronald BuckanovichNCT05538091

~$75 – $3,000

Actual pay is set by the research site.

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Gastroparesis With Diabetes Mellitus

Glucose Metrics Using Freestyle Libre 3 Real-Time Continuous Glucose Monitor (rtCGM) in Patients With Gastroparesis in Type 1 or Type 2 Diabetes: Investigator Initiated Pilot Study

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes an…

~$10 – $1,125

Actual pay is set by the research site.

Samita GargNCT06046833

Phase 2

IZABRIGHT-Breast01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase in…

Breast Neoplasms